- Home
- NNNN vs ESBA Comparison
NNNN vs ESBA Comparison
Compare NNNN & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- ESBA
- Stock Information
- Founded
- NNNN 2021
- ESBA N/A
- Country
- NNNN Germany
- ESBA United States
- Employees
- NNNN N/A
- ESBA N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ESBA
- Sector
- NNNN Health Care
- ESBA
- Exchange
- NNNN Nasdaq
- ESBA NYSE
- Market Cap
- NNNN 2.2B
- ESBA 2.0B
- IPO Year
- NNNN 2025
- ESBA 2013
- Fundamental
- Price
- NNNN $42.80
- ESBA $6.84
- Analyst Decision
- NNNN
- ESBA
- Analyst Count
- NNNN 0
- ESBA 0
- Target Price
- NNNN N/A
- ESBA N/A
- AVG Volume (30 Days)
- NNNN 147.4K
- ESBA 3.8K
- Earning Date
- NNNN 01-01-0001
- ESBA 01-01-0001
- Dividend Yield
- NNNN N/A
- ESBA 2.01%
- EPS Growth
- NNNN N/A
- ESBA 3.47
- EPS
- NNNN 0.06
- ESBA 0.30
- Revenue
- NNNN $8,185,146.00
- ESBA $762,039,000.00
- Revenue This Year
- NNNN N/A
- ESBA N/A
- Revenue Next Year
- NNNN N/A
- ESBA N/A
- P/E Ratio
- NNNN $776.89
- ESBA $23.90
- Revenue Growth
- NNNN 21.95
- ESBA 0.78
- 52 Week Low
- NNNN $5.18
- ESBA $6.39
- 52 Week High
- NNNN $55.65
- ESBA $11.50
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- ESBA 28.87
- Support Level
- NNNN N/A
- ESBA $7.14
- Resistance Level
- NNNN N/A
- ESBA $7.40
- Average True Range (ATR)
- NNNN 0.00
- ESBA 0.18
- MACD
- NNNN 0.00
- ESBA -0.08
- Stochastic Oscillator
- NNNN 0.00
- ESBA 0.00
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is an NYC-focused real estate investment trust (REIT) that owns and operates a portfolio of well-leased, top-of-tier, modernized, amenitized, and well-located office, retail, and multifamily assets, conducts all of its business and owns substantially all of its assets. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.